Categories: NewsPharmaceutical

Reviva to Present at the 36th Annual ROTH Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CUPERTINO, Calif., March 07, 2024 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the 36th Annual ROTH Conference, taking place March 17-19, 2024, in Dana Point, CA.

36th Annual ROTH Conference
Format: Presentation and one-on-one investor meetings
Date: Tuesday, March 19, 2024
Time: 2:00 p.m. PT
Location: Dana Point, CA
Webcast Link: Click Here

Please contact your ROTH representative to register for the conference and schedule a one-on-one meeting with Reviva management.

About Reviva 
Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. Reviva’s current pipeline focuses on the central nervous system, respiratory and metabolic diseases. Reviva’s pipeline currently includes two drug candidates, brilaroxazine (RP5063) and RP1208. Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both brilaroxazine and RP1208 in the United States, Europe, and several other countries.

Corporate Contact:
Reviva Pharmaceuticals Holdings, Inc.
Laxminarayan Bhat, PhD 
www.revivapharma.com

Investor Relations Contact:
LifeSci Advisors, LLC
Bruce Mackle
bmackle@lifesciadvisors.com

Media Contact:
Kristin Politi
kpoliti@lifescicomms.com
(646) 876-4783

Staff

Recent Posts

CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for…

4 hours ago

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release…

4 hours ago

inTouch Addresses $6.7 Billion Senior Loneliness Crisis with Launch of AI Conversational Companion for North America

Complements Family Interactions & Supports Sandwich Generation of Caregivers with Daily Phone Calls to Seniors…

4 hours ago

AI in Healthcare: MENA Region on the Verge of a Major Breakthrough

"Comprehensive Analysis of MENA's AI Healthcare Market: Emerging Opportunities and Challenges, with a Projected CAGR…

4 hours ago

Global Excel Acquires First Assistance to Strengthen Assistance Services and Expand in the Asia-Pacific Market

SHERBROOKE QC, July 2, 2025 /PRNewswire/ - Global Excel Management Inc. (Global Excel) is pleased…

4 hours ago

Single Pass Inc. Launches Global Post-Market Evaluation of the Biopsy Tract Closure Device

The evaluation will include 1,000 unique procedures across 20 centers worldwide to capture real-world evidence…

10 hours ago